These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 21966454)
1. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. Davis LM; Martínez I; Walter J; Goin C; Hutkins RW PLoS One; 2011; 6(9):e25200. PubMed ID: 21966454 [TBL] [Abstract][Full Text] [Related]
2. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Davis LM; Martínez I; Walter J; Hutkins R Int J Food Microbiol; 2010 Dec; 144(2):285-92. PubMed ID: 21059476 [TBL] [Abstract][Full Text] [Related]
3. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454 [TBL] [Abstract][Full Text] [Related]
4. Diverse galactooligosaccharides consumption by bifidobacteria: implications of β-galactosidase--LacS operon. Akiyama T; Kimura K; Hatano H Biosci Biotechnol Biochem; 2015; 79(4):664-72. PubMed ID: 25483279 [TBL] [Abstract][Full Text] [Related]
5. Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes. Stiverson J; Williams T; Chen J; Adams S; Hustead D; Price P; Guerrieri J; Deacon J; Yu Z Appl Environ Microbiol; 2014 Dec; 80(23):7388-97. PubMed ID: 25239906 [TBL] [Abstract][Full Text] [Related]
6. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Vulevic J; Juric A; Walton GE; Claus SP; Tzortzis G; Toward RE; Gibson GR Br J Nutr; 2015 Aug; 114(4):586-95. PubMed ID: 26218845 [TBL] [Abstract][Full Text] [Related]
7. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273 [TBL] [Abstract][Full Text] [Related]
8. Prebiotic effects of a novel combination of galactooligosaccharides and maltodextrins. Musilova S; Rada V; Marounek M; Nevoral J; Dušková D; Bunesova V; Vlkova E; Zelenka R J Med Food; 2015 Jun; 18(6):685-9. PubMed ID: 25525835 [TBL] [Abstract][Full Text] [Related]
9. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Monteagudo-Mera A; Arthur JC; Jobin C; Keku T; Bruno-Barcena JM; Azcarate-Peril MA Benef Microbes; 2016; 7(2):247-64. PubMed ID: 26839072 [TBL] [Abstract][Full Text] [Related]
10. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters. Grimaldi R; Swann JR; Vulevic J; Gibson GR; Costabile A Br J Nutr; 2016 Aug; 116(3):480-6. PubMed ID: 27267934 [TBL] [Abstract][Full Text] [Related]
11. Combinational effects of prebiotic oligosaccharides on bifidobacterial growth and host gene expression in a simplified mixed culture model and neonatal mice. Ehara T; Izumi H; Tsuda M; Nakazato Y; Iwamoto H; Namba K; Takeda Y Br J Nutr; 2016 Jul; 116(2):270-8. PubMed ID: 27198516 [TBL] [Abstract][Full Text] [Related]
12. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. Scalabrin DM; Mitmesser SH; Welling GW; Harris CL; Marunycz JD; Walker DC; Bos NA; Tölkkö S; Salminen S; Vanderhoof JA J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):343-52. PubMed ID: 21946836 [TBL] [Abstract][Full Text] [Related]
13. The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut. Arnold JW; Roach J; Fabela S; Moorfield E; Ding S; Blue E; Dagher S; Magness S; Tamayo R; Bruno-Barcena JM; Azcarate-Peril MA Microbiome; 2021 Jan; 9(1):31. PubMed ID: 33509277 [TBL] [Abstract][Full Text] [Related]
14. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. Vulevic J; Juric A; Tzortzis G; Gibson GR J Nutr; 2013 Mar; 143(3):324-31. PubMed ID: 23303873 [TBL] [Abstract][Full Text] [Related]
15. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. Veereman-Wauters G; Staelens S; Van de Broek H; Plaskie K; Wesling F; Roger LC; McCartney AL; Assam P J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):763-71. PubMed ID: 21593649 [TBL] [Abstract][Full Text] [Related]
16. [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption]. Luo YM; Liu FT; Chen MX; Tang WL; Yang YL; Tan XL; Zhou HW Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):251-260. PubMed ID: 29643029 [TBL] [Abstract][Full Text] [Related]
17. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Walton GE; van den Heuvel EG; Kosters MH; Rastall RA; Tuohy KM; Gibson GR Br J Nutr; 2012 May; 107(10):1466-75. PubMed ID: 21910949 [TBL] [Abstract][Full Text] [Related]
18. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Azcarate-Peril MA; Ritter AJ; Savaiano D; Monteagudo-Mera A; Anderson C; Magness ST; Klaenhammer TR Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E367-E375. PubMed ID: 28049818 [TBL] [Abstract][Full Text] [Related]
19. Revealing new leads for the impact of galacto-oligosaccharides on gut commensals and gut health benefits through text mining. Sijbers AM; Schoemaker RJW; Nauta A; Alkema W Benef Microbes; 2020 May; 11(3):283-302. PubMed ID: 32299221 [TBL] [Abstract][Full Text] [Related]
20. Exploring the modulatory effect of trehalose-derived galactooligosaccharides on key gut microbiota groups. Calvete-Torre I; Sabater C; Villamiel M; Margolles A; Méndez-Albiñana P; Ruiz L; Hernandez-Hernandez O Int J Biol Macromol; 2024 Jul; 273(Pt 1):133053. PubMed ID: 38857723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]